Skip to main content
. 2020 Jun 14;26(22):2931–2947. doi: 10.3748/wjg.v26.i22.2931

Figure 2.

Figure 2

Proposed time-line for liver-related effects of direct-acting antiviral therapy. DAA: Direct-acting antiviral; EOT: End of treatment; SVR12: Sustained virologic response at 12 wk post-treatment; SVR52: Sustained virologic response 1 year after treatment.